Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival

Table 2

Proportion of relapse according to the treatment and number of invaded nodes (1 or >1). Data obtained in June 2000, April 2006, and March 2013.

	TIL + IL-2			IL-2			All
	2000	2006	2013	2000	2006	2013	2000	2006	2013
1 invaded node	5/15		7/15	13/19		16/19	18/34		23/34
	(33.3%)		(46.66%)	(68.42%)		(84.21%)	(52.94%)		(67.64%)
>1 invaded node	24/29		26/29	18/25	19/25	21/25	42/54	43/54	47/54
	(82.75%)		(89.65%)	(72%)	(76%)	(84%)	(77.8%)	(79.6%)	(87.03%)
All	29/44		33/44	31/44	32/44	37/44	60/88	61/88	70/88
	(65.9%)		(75%)	(70.5%)	(72.7%)	(84.09%)	(68.18%)	(69.3%)	(79.54%)